indirubin has been researched along with hymenialdisine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoda, N; Maqbool, M; Mobashir, M | 1 |
| Alam, MS; Hamid, H; Khan, I; Tantray, MA | 1 |
| Bai, BM; Kumar, A; Nisha, CM; Pal, D; Vimal, A | 1 |
| Abbaszadeh, S; Asadi-Samani, M; Ashrafi-Dehkordi, K; Basati, G; Saffari-Chaleshtori, J | 1 |
2 review(s) available for indirubin and hymenialdisine
| Article | Year |
|---|---|
Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Diabetes Mellitus; Glycogen Synthase Kinase 3; Hippocampus; Humans; Hypoglycemic Agents; Inflammation; Molecular Targeted Therapy; Neoplasms; Protein Kinase Inhibitors | 2016 |
Natural and synthetic bioactive inhibitors of glycogen synthase kinase.
Topics: Alzheimer Disease; Animals; Bipolar Disorder; Clinical Trials as Topic; Diabetes Mellitus; Drug Discovery; Glycogen Synthase Kinase 3; Humans; Models, Molecular; Neoplasms; Patents as Topic; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction | 2017 |
2 other study(ies) available for indirubin and hymenialdisine
| Article | Year |
|---|---|
Docking and ADMET prediction of few GSK-3 inhibitors divulges 6-bromoindirubin-3-oxime as a potential inhibitor.
Topics: Azepines; Binding Sites; Glycogen Synthase Kinase 3 beta; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Hypoglycemic Agents; Indole Alkaloids; Indoles; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Oximes; Protein Binding; Protein Interaction Domains and Motifs; Protein Kinase Inhibitors; Protein Structure, Secondary; Pyrroles; Static Electricity; Thermodynamics; Thiadiazoles | 2016 |
Molecular Dynamics Mechanisms of the Inhibitory Effects of Abemaciclib, Hymenialdisine, and Indirubin on CDK-6.
Topics: Aminopyridines; Antineoplastic Agents; Azepines; Benzimidazoles; Binding Sites; Cell Cycle Checkpoints; Computer Simulation; Cyclin-Dependent Kinase 6; Humans; Hydrogen Bonding; Indoles; Models, Molecular; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Kinase Inhibitors; Pyrroles | 2019 |